These patients carried a compound-heterozygous mutation in IGHMBP2. Moreover, in 2015, Hamilton et al. reported a 21-year-old female patient with SMARD1 (juvenile SMARD1) whose diagnosis was genetically confirmed [85]. This evidence concerns the gene IGHMBP2 and Spinal muscular atrophy with respiratory distress type 1.